We have provided evidence that inhibition of QSOX1 activity by ebselen leads to significantly decreased invasion of tumor cell lines in vitro and reduced tumor growth in vitro and in vivo, effects comparable to QSOX1 knockdown. Here, QSOX1 is linked to neoplasm.